Back to Search
Start Over
Transhiatal and Transthoracic Esophagectomy for Adenocarcinoma of the Esophagus
- Source :
- Archives of Surgery; August 1992, Vol. 127 Issue: 8 p951-955, 5p
- Publication Year :
- 1992
-
Abstract
- • Adenocarcinoma of the esophagus is no longer rare and is treated by resection. To determine whether the approach used for resection influences outcome, we studied 88 patients who underwent resection; 14 had stage I or II disease, 74 had stage III, and 40 had stage IV. One third of those with Barrett's esophagus were noted on screening endoscopy to have potentially curable disease; the others were diagnosed with stage III or IV disease. Transhiatal esophagectomy was performed in 63 patients; 24 patients underwent transthoracic esophagectomy. We found no difference in survival or morbidity between transhiatal and transthoracic esophagectomy. Overall 5-year survival for stage I and II disease was 86%. For stage III and IV disease, 5-year survival was 14.5%. Aggressive surveillance of Barrett's esophagus facilitates the discovery of early disease. Esophagectomy for adenocarcinoma can result in cure of early cancers and improved palliation of more advanced disease.(Arch Surg. 1992;127:951-955)
Details
- Language :
- English
- ISSN :
- 00040010 and 15383644
- Volume :
- 127
- Issue :
- 8
- Database :
- Supplemental Index
- Journal :
- Archives of Surgery
- Publication Type :
- Periodical
- Accession number :
- ejs27717035
- Full Text :
- https://doi.org/10.1001/archsurg.1992.01420080085013